Stay updated on Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Sign up to get notified when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.

Latest updates to the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page's revision line now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects a minor update to the page's metadata/history rather than any change to trial details or content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3 in the page footer. This indicates a small system/version update rather than a change to the study content.SummaryDifference0.1%

- Check39 days agoChange DetectedFooter revision indicator updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision v3.5.0 has been added. Revision v3.4.3 has been removed.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded 'Gastric cancer' as a condition/topic and included a resources entry for Genetic and Rare Diseases Information Center related to gastric cancer.SummaryDifference0.2%

Stay in the know with updates to Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.